IRHYTHM TECHNOLOGIES

iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments

06 Jun 2023 09:00:39 By Nasdaq GlobeNewswire

iRhythm Technologies to Present at the William Blair 43rd Annual Growth Stock Conference

24 May 2023 16:05:00 By Nasdaq GlobeNewswire

New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias

22 May 2023 08:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies Announces First Quarter 2023 Financial Results

04 May 2023 16:05:01 By Nasdaq GlobeNewswire

iRhythm Technologies to Report First Quarter 2023 Financial Results on May 4, 2023

20 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies Releases 2022 Environmental, Social, and Governance Report Reflecting Strategy to Deliver Purpose-Driven Growth

12 Apr 2023 16:30:00 By Nasdaq GlobeNewswire

Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors

06 Mar 2023 08:30:00 By Nasdaq GlobeNewswire

Four New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC

02 Mar 2023 08:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results

23 Feb 2023 16:05:01 By Nasdaq GlobeNewswire

iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

09 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference

09 Jan 2023 08:30:00 By Nasdaq GlobeNewswire

iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference

27 Dec 2022 16:30:00 By Nasdaq GlobeNewswire

Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

07 Nov 2022 16:05:03 By Nasdaq GlobeNewswire

New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective

06 Nov 2022 12:30:00 By Nasdaq GlobeNewswire

iRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023

02 Nov 2022 17:45:00 By Nasdaq GlobeNewswire

iRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023

02 Nov 2022 08:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies Announces Third Quarter 2022 Financial Results

01 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022

20 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day

21 Sep 2022 08:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022

31 Aug 2022 08:30:00 By Nasdaq GlobeNewswire